National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

A new study published in the peer-reviewed journal Human Gene Therapy involved the generation of a human monoclonal antibody ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several ...

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Part B of the LIGHTHOUSE study will enroll adults and children. DURHAM, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...